论文部分内容阅读
报道出血性脑梗塞(HI)和非出血性脑梗塞(NHI)患者各49例,对其中长期口服阿司匹林及脑梗塞早期应用降纤酶治疗者进行了相关性分析,并观察其对发病后1个月临床神经功能缺损程度评分减少值的影响。结果显示,长期口服阿司匹林及脑梗塞早期应用降纤酶治疗与梗塞后出血关系密切,但其发病后1个月的临床神经功能缺损程度评分减少值明显大于不用阿司匹林和降纤酶者。说明长期口服阿司匹林及脑梗塞早期应用降纤酶治疗虽是梗塞后出血的易发因素,但对脑功能的恢复是有利的。
Reported 49 cases of hemorrhagic cerebral infarction (HI) and non-hemorrhagic cerebral infarction (NHI), 49 cases were treated with aspirin and long-term oral administration of defibrase in cerebral infarction, Month clinical neurological deficit score reduction effect. The results showed that long-term oral aspirin and cerebral infarction in the early application of defibrase treatment and post-infarction bleeding is closely related, but the 1-month after the onset of clinical neurological deficit score reduction was significantly greater than those without aspirin and defibrase. Explain long-term oral aspirin and cerebral infarction in the early application of defibrase is a predisposing factor for post-infarction bleeding, but the recovery of brain function is beneficial.